nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
|
O’Donnell, Michael A. |
|
2019 |
5 |
2 |
p. 171-180 |
artikel |
2 |
Asymptomatic Microscopic Haematuria and Significant Urinary Tract Disease
|
Bryan, Richard T. |
|
2019 |
5 |
2 |
p. 115-117 |
artikel |
3 |
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
|
Masson-Lecomte, Alexandra |
|
2019 |
5 |
2 |
p. 159-169 |
artikel |
4 |
Challenging Cases in Urothelial Cancer
|
Soloway, Mark S. |
|
2019 |
5 |
2 |
p. 181-183 |
artikel |
5 |
Clinical Development of FGFR3 Inhibitors for the Treatment of Urothelial Cancer
|
Ibrahim, Tony |
|
2019 |
5 |
2 |
p. 87-102 |
artikel |
6 |
Clinical Trials Corner
|
Agarwal, Piyush K. |
|
2019 |
5 |
2 |
p. 185-187 |
artikel |
7 |
Evaluation of Hematuria in a Large Public Health Care System
|
Ghandour, Rashed |
|
2019 |
5 |
2 |
p. 119-129 |
artikel |
8 |
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer1
|
Tu, Megan M. |
|
|
5 |
2 |
p. 131-145 |
artikel |
9 |
MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation
|
Walker, Alexandra K. |
|
2019 |
5 |
2 |
p. 147-157 |
artikel |
10 |
Preventing Bladder Recurrences after Nephroureterectomy for Upper Track Urothelial Cancer
|
Messing, Edward M. |
|
2019 |
5 |
2 |
p. 189-191 |
artikel |
11 |
The Role of Myeloid Derived Suppressor Cells in Urothelial Carcinoma Immunotherapy
|
Puttmann, Kathleen |
|
2019 |
5 |
2 |
p. 103-114 |
artikel |